Received Jul 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | ER2613 | LA |
fever; sick; aches, pains; knee replacement surgery in January; This is a spontaneous report received from a Consumer or other non HCP from medical information team, Program ID. A 62-year-old female patient received BNT162b2 (BNT162B2), on 17Mar2021 as dose 1, single (Lot number: ER2613) at the age of 62 years, in left arm for COVID-19 immunisation. The patient's relevant medical history included: "Blood pressure high" (unspecified if ongoing); "Weight loss" (unspecified if ongoing); "ADHD" (unspecified if ongoing). Concomitant medication(s) included: ZEPBOUND taken for weight decreased (ongoing); NEVIBOLOL DCI taken for hypertension (ongoing); METHYLPHENIDATE taken for attention deficit hyperactivity disorder (ongoing). The following information was reported: KNEE ARTHROPLASTY (medically significant) with onset 21Jan2025, outcome "unknown", described as "knee replacement surgery in January"; PYREXIA (non-serious), outcome "unknown", described as "fever"; ILLNESS (non-serious), outcome "unknown", described as "sick"; PAIN (non-serious), outcome "unknown" and all described as "aches, pains". Clinical course: the patient reported that when she got a covid vaccine, she experienced a fever within few hours and got pretty sick. She had aches, pains and a fever. She also had knee replacement surgery in Jan, so she thought perhaps that had something to do with her experience.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202500132274 Same patient and drug, different dose and event;
Medical History/Concurrent Conditions: ADHD; Blood pressure high; Weight loss
ZEPBOUND; NEVIBOLOL DCI; METHYLPHENIDATE